Compare RBC & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RBC | ZBH |
|---|---|---|
| Founded | 1919 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5B | 17.6B |
| IPO Year | N/A | 2001 |
| Metric | RBC | ZBH |
|---|---|---|
| Price | $559.18 | $98.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 19 |
| Target Price | ★ $495.83 | $105.17 |
| AVG Volume (30 Days) | 206.9K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.55 |
| Revenue | N/A | ★ $8,231,500,000.00 |
| Revenue This Year | $14.83 | $4.91 |
| Revenue Next Year | $12.08 | $3.65 |
| P/E Ratio | $64.90 | ★ $34.92 |
| Revenue Growth | N/A | ★ 7.20 |
| 52 Week Low | $297.28 | $84.59 |
| 52 Week High | $564.70 | $114.44 |
| Indicator | RBC | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 77.95 | 71.22 |
| Support Level | $545.51 | $90.22 |
| Resistance Level | $564.70 | $99.57 |
| Average True Range (ATR) | 13.95 | 2.53 |
| MACD | 0.05 | 1.19 |
| Stochastic Oscillator | 80.62 | 91.17 |
RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.